NCT00042783View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Stage IV Melanoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2002

Study Completion Date

March 31, 2006

Conditions
Melanoma (Skin)
Interventions
BIOLOGICAL

D1/3-MAGE-3-His fusion protein

BIOLOGICAL

SB-AS02B adjuvant

Trial Locations (7)

85724

Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson

90033

USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles

97225

CCOP - Columbia River Oncology Program, Portland

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

48201-1379

Barbara Ann Karmanos Cancer Institute, Detroit

39531-2410

Veterans Affairs Medical Center - Biloxi, Biloxi

98195-6527

University of Washington School of Medicine, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

SWOG Cancer Research Network

NETWORK

NCT00042783 - Vaccine Therapy in Treating Patients With Stage IV Melanoma | Biotech Hunter | Biotech Hunter